Brief: Bausch + Lomb Announces Statistically Significant Results From Clinical Study Of Novel Daily Nutritional Supplement

Bausch + Lomb

25/04/2024 14:13

April 25 (Reuters) - Bausch + Lomb Corp  BLCO.TO :
    * BAUSCH + LOMB ANNOUNCES STATISTICALLY SIGNIFICANT RESULTS
FROM A
CLINICAL STUDY OF A NOVEL DAILY NUTRITIONAL SUPPLEMENT FOR DRY
EYES
    * BAUSCH + LOMB CORP: CLINICAL STUDY MET BOTH PRIMARY
ENDPOINTS
    * BAUSCH + LOMB CORP: STUDY ALSO MET SECONDARY ENDPOINTS
    * BAUSCH + LOMB CORP: NO SERIOUS ADVERSE EVENTS WERE
REPORTED
DURING STUDY PERIOD
    * BAUSCH + LOMB CORP: NUTRITEARS WAS FOUND TO BE
WELL-TOLERATED

Source text for Eikon:  ID:nBw9J9RH5a 
Further company coverage:  BLCO.TO 

 ((Reuters.Briefs@thomsonreuters.com;))